AU2028297A - Method for predicting the outcome of hepatitis b infection - Google Patents

Method for predicting the outcome of hepatitis b infection

Info

Publication number
AU2028297A
AU2028297A AU20282/97A AU2028297A AU2028297A AU 2028297 A AU2028297 A AU 2028297A AU 20282/97 A AU20282/97 A AU 20282/97A AU 2028297 A AU2028297 A AU 2028297A AU 2028297 A AU2028297 A AU 2028297A
Authority
AU
Australia
Prior art keywords
hepatitis
outcome
predicting
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20282/97A
Inventor
Rudolf Arnold Heijtink
Wilhelmina Petronella Paulij
Markus Hendrikus Van Roosmalen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of AU2028297A publication Critical patent/AU2028297A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
AU20282/97A 1996-03-19 1997-03-17 Method for predicting the outcome of hepatitis b infection Abandoned AU2028297A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP96200758 1996-03-19
EP96200758 1996-03-19
PCT/EP1997/001351 WO1997035204A1 (en) 1996-03-19 1997-03-17 Method for predicting the outcome of hepatitis b infection

Publications (1)

Publication Number Publication Date
AU2028297A true AU2028297A (en) 1997-10-10

Family

ID=8223798

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20282/97A Abandoned AU2028297A (en) 1996-03-19 1997-03-17 Method for predicting the outcome of hepatitis b infection

Country Status (6)

Country Link
EP (1) EP0888551A1 (en)
JP (1) JP2000506735A (en)
KR (1) KR20000064637A (en)
AU (1) AU2028297A (en)
CA (1) CA2250076A1 (en)
WO (1) WO1997035204A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2419046C (en) * 2000-08-11 2007-10-02 Advanced Life Science Institute, Inc. Method for detecting or measuring hbv
US20090280474A1 (en) * 2008-05-08 2009-11-12 Abbott Laboratories Method for detecting a virus
WO2011123044A1 (en) * 2010-03-31 2011-10-06 Anamar Ab Method to detect tissue degradation leading to inflammation
EP3655430A1 (en) * 2017-07-19 2020-05-27 The U.S.A. as represented by the Secretary, Department of Health and Human Services Antibodies and methods for the diagnosis and treatment of hepatitis b virus infection
US20210239700A1 (en) * 2018-05-04 2021-08-05 Abbott Laboratories Hbv diagnostic, prognostic, and therapeutic methods and products
CN111879923A (en) * 2020-08-06 2020-11-03 深圳科隆生物新材料有限公司 Kit capable of eliminating HAMA effect

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1123733A (en) * 1977-12-14 1982-05-18 Isa K. Mushahwar Hepatitis be-antigen and antibodies in insoluble form
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
US4459359A (en) * 1981-11-19 1984-07-10 New York Blood Center, Inc. Sensitive immunoassays of antigens or antibodies sequestered within immune complexes
AU5362094A (en) * 1992-10-14 1994-05-09 Scripps Research Institute, The Methods for the detection of antigen-specific immune complexes
JPH06321991A (en) * 1993-05-14 1994-11-22 Mitsubishi Kasei Corp Polypeptide derived from hepatitis b virus and gene coding the same
US5726011A (en) * 1994-03-31 1998-03-10 Virginia Commonwealth University Method for diagnosing chronic hepatitis B virus infection
JP3401690B2 (en) * 1994-07-11 2003-04-28 富士レビオ株式会社 Novel polypeptide and method for immunoassay of anti-hepatitis B virus e antigen antibody using the same

Also Published As

Publication number Publication date
EP0888551A1 (en) 1999-01-07
JP2000506735A (en) 2000-06-06
KR20000064637A (en) 2000-11-06
CA2250076A1 (en) 1997-09-25
WO1997035204A1 (en) 1997-09-25

Similar Documents

Publication Publication Date Title
AU3338697A (en) Method of controlling vehicle handling
AU3890795A (en) Improved method for nucleotide sequence amplification
AU2448797A (en) Methods of providing neuroprotection
KR100201051B1 (en) The method for culturing cordyceps
AU3587297A (en) Method for accelerating production-c-i-p
AU3661797A (en) Method for activation of bleaches
AU1501697A (en) Improved method for the detection of protein
AU3444899A (en) Method for the rapid determination of bacteria
AU2165095A (en) Magnesia-titania refractory and method for manufacturing the same
AU6425696A (en) Method of operating an inductor and inductor for carrying out the method
EP0844556A3 (en) Software updating method
AU2183997A (en) New method
AU2028297A (en) Method for predicting the outcome of hepatitis b infection
AU7944398A (en) Method for determining the energy-information characteristics of a biological object
AU2532295A (en) Method of genetic testing
AU7063298A (en) Etching method
AU7506896A (en) Method for the simultaneous detection of polygenes
AUPO870297A0 (en) Method
AUPO937097A0 (en) Method
AU7558998A (en) Method for reinforcing
AU2550497A (en) Simplified bimodal process
AU6455198A (en) Method for the identification of genetic subtypes
AU6623096A (en) Methods of predicting the outcome of infection
AU5271296A (en) Novel method
AU2797395A (en) Method for the manufacture of halogenoalcanols

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted